Literature DB >> 12195449

The impact of outpatient rehabilitation on quality of life in multiple sclerosis.

Francesco Patti1, Maria Rita Ciancio, Ester Reggio, Rossella Lopes, Filippo Palermo, Manuela Cacopardo, Arturo Reggio.   

Abstract

It is well accepted that rehabilitative treatment can be effective in reducing disability and optimizing quality of life (QoL) of people with multiple sclerosis (MS). The aim of this study was to evaluate the effects of a comprehensive outpatient rehabilitative treatment on QoL in patients suffering from MS. We selected 111 patients from a sample of 407 patients who had consecutively entered the MS Center of Catania (which is located in southern Italy) in 1998. Fifty-eight were randomly assigned to the study treatment and 53 to a waiting list (control treatment). Kurtzke's EDSS and quality of Life (QoL)were the primary endpoints. QoL was measured with the generic multi-item SF-36 scales. We also used: the Beck Depression Inventory (BDI) for depression, the Tempelaar Social Experience Check-list (SET) for social activities and the Fatigue Impact Scale (FIS). The study treatment group was treated for 6 consecutive weeks, 6 days a week with a comprehensive rehabilitative outpatient model. The control treatment group was in a waiting list and was trained to self-exercises at home. EDSS remained unchanged in both groups. All health related QoL domains significantly improved in the study treatment (p < 0.001 in physical functioning, role physical, bodily pain, general health, and social functioning; p < 0.05 in vitality, role emotional and mental health). FIS, SET and BDI also improved significantly after the rehabilitative treatment in the study group (p < 0.001). The results of this study confirm the effectiveness of a short comprehensive outpatient model of rehabilitative treatment in people with MS and in particular in their QoL.

Entities:  

Mesh:

Year:  2002        PMID: 12195449     DOI: 10.1007/s00415-002-0778-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  A novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients.

Authors:  Regina Rendas-Baum; Min Yang; Francoise Cattelin; Gene V Wallenstein; John D Fisk
Journal:  Qual Life Res       Date:  2010-07-10       Impact factor: 4.147

2.  Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Authors:  Annett Apel; Brigitte Greim; Nicolaus König; Uwe K Zettl
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

3.  Therapy Caps and Variation in Cost of Outpatient Occupational Therapy by Provider, Insurance Status, and Geographic Region.

Authors:  Mackenzi Pergolotti; Jessica Lavery; Bryce B Reeve; Stacie B Dusetzina
Journal:  Am J Occup Ther       Date:  2018 Mar/Apr

Review 4.  [Quality of life in multiple sclerosis. Measures, relevance, problems, and perspectives].

Authors:  W Pöllmann; C Busch; R Voltz
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

5.  Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis.

Authors:  Elda Judica; Filippo Martinelli Boneschi; Daniela Ungaro; Mauro Comola; Roberto Gatti; Giancarlo Comi; Paolo Rossi
Journal:  J Neurol       Date:  2011-01-15       Impact factor: 4.849

6.  Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Authors:  Fary Khan; Bhasker Amatya; Jürg Kesselring
Journal:  J Neurol       Date:  2013-04-25       Impact factor: 4.849

Review 7.  Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Jodie K Haselkorn; Christina Hughes; Alex Rae-Grant; Lily Jung Henson; Christopher T Bever; Albert C Lo; Theodore R Brown; George H Kraft; Thomas Getchius; Gary Gronseth; Melissa J Armstrong; Pushpa Narayanaswami
Journal:  Neurology       Date:  2015-11-24       Impact factor: 9.910

Review 8.  [New aspects of symptomatic MS treatment: Part 6 - cognitive dysfunction and rehabilitation].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

9.  [Multimodal complex treatment in multiple sclerosis : influence on motor performance and need of care].

Authors:  D Ecker; E Mauch; M Sabolek
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 10.  Psychosocial interventions in people with multiple sclerosis: a review.

Authors:  K S Malcomson; L Dunwoody; A S Lowe-Strong
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.